top of page
Asian Institute of Research, Journal Publication, Journal Academics, Education Journal, Asian Institute
Asian Institute of Research, Journal Publication, Journal Academics, Education Journal, Asian Institute

Journal of Health and Medical Sciences

ISSN 2622-7258

Screen Shot 2018-08-12 at 1.24.09 AM.png
Screen Shot 2018-08-12 at 1.24.02 AM.png
Screen Shot 2018-08-12 at 1.23.57 AM.png
Screen Shot 2018-08-12 at 1.23.52 AM.png
crossref
doi
open access

Published: 27 March 2020

Combination Therapy with TACE and Microwave Ablation to Increase Efficacy of Hepatocellular Carcinoma Treatment

Muhammad Fiaz, Ammara Saeed Malik, Muhammad Ramazan

Superior University Azra Naheed Medical College and Alrazi Hospital, Pakistan

journal of social and political sciences
pdf download

Download Full-Text Pdf

doi

10.31014/aior.1994.03.01.103

Pages: 98-103

Keywords: Hepatocellular Carcinoma, Microwave Ablation, Transarterial Chemoembolization

Abstract

To evaluate efficacy of microwave ablation (MWA) combined with conventional transarterial chemoembolization (cTACE) simultaneously or vice versa for the treatment of large hepatocellular carcinoma (HCC). Study was done from March 2017 and February 2019 and a total number of 66 patients with large hepatocellular carcinoma received TACE and ultrasound-guided percutaneous MWA combined with simultaneous TACE. Patients with primary liver cancer aged from 18-80 years, and life expectancy longer than three months were included. Ablation with different techniques were used along with standard doxorubicin TACE. As result, it was concluded that the combined treatment model is superior to single TACE.

References

  1. Tamandl D, Herberger B, Gruenberger B, Puhalla H, Klinger M, Gruenberger T. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2008;15:2787–2794.  [PubMed]
  2. Gusani NJ, Balaa FK, Steel JL, et al. Treatment of unresectable cholan-giocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience. J Gastrointest Surg. 2008;12:129–137.  [PubMed]
  3. Ahmed M, Solbiati L, Brace CL, et al. International Working Group on Image-guided Tumor Ablation. Interventional Oncology Sans Frontières Expert Panel. Technology Assessment Committee of the Society of Interventional Radiology. Standard of Practice Committee of the Cardiovascular. Interventional Radiological Society of Europe Image-guided tumor ablation: standardization of terminology and reporting criteria – a 10-year update. Radiology. 2014;273:241–260. [PMC free article]  [PubMed]
  4. Garrean S, Hering J, Saied A, Helton WS, Espat NJ. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg. 2008;195:508–520.  [PubMed]
  5. Boutros C, Somasundar P, Garrean S, Saied A, Espat NJ. Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis. Surg Oncol. 2010;19:e22–e32.  [PubMed]
  6. Morimoto M, Numata K, Kondo M, et al. Radiofrequency ablation combined with transarterial chemoembolization for subcapsular hepatocellular carcinoma: a prospective cohort study. Eur J Radiol. 2013;82:497–503.  [PubMed]
  7. Peng ZW, Chen MS, Liang HH, et al. A case-control study comparing percutaneous radiofrequency ablation alone or combined with tran-scatheter arterial chemoembolization for hepatocellular carcinoma. Eur J Surg Oncol. 2010;36:257–263.  [PubMed]
  8. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A., III . AJCC Cancer Staging Manual.7th ed. New York: Springer; 2010.
  9. Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268–1289.  [PubMed]
  10. Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30:52–60.  [PubMed]
  11. Yu MA, Liang P, Yu XL, et al. Sonography-guided percutaneous microwave ablation of intrahepatic primary cholangiocarcinoma. Eur J Radiol. 2011;80:548–552.  [PubMed]
  12. Livraghi T, Meloni F, Solbiati L, Zanus G, Collaborative Italian Group using AMICA system Complications of microwave ablation for liver tumors: results of a multicenter study. Cardiovasc Intervent Radiol. 2012;35:868–874.  [PubMed]
  13. Butros SR, Shenoy-Bhangle A, Mueller PR, Arellano RS. Radiof-requency ablation of intrahepatic cholangiocarcinoma: feasability, local tumor control, and long-term outcome. Clin Imaging. 2014;38:490–494.  [PubMed]
  14. Seki T, Tamai T, Nakagawa T, et al. Combination therapy with tran-scatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer. 2000;89:1245–1251.  [PubMed]
  15. Herber S, Otto G, Schneider J, et al. Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma. Cardiovasc Intervent Radiol. 2007;30:1156–1165.  [PubMed]
  16. Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: treatment with percutaneous microwave ablation – complications among cohort of 1136 patients. Radiology. 2009;251:933–940.  [PubMed]
  17. Kim JW, Kim JH, Won HJ, et al. Hepatocellular carcinomas 2–3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs radiofrequency ablation alone. Eur J Radiol. 2012;81:e189–e193.  [PubMed]
  18. Zhao M, Wang JP, Pan CC, et al. CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement. Eur J Radiol. 2012;81:2717–2725.  [PubMed]
  19. Edwards A, Ray CE., Jr Abstract No. 247: Transarterial therapies for unresectable cholangiocarcinoma: a meta-analysis. J Vasc Interv Radiol. 2012;23:S101.
  20. Zhao Q, Qian S, Zhu L, et al. Transcatheter arterial chemoembolization with gemcitabine and oxaliplatin for the treatment of advanced biliary tract cancer. Onco Targets Ther. 2015;8:595–600.[PMC free article]  [PubMed]
bottom of page